Skip to content

Open Lung Protective Ventilation in Cardiac Surgery

Open Lung Protective Ventilation During Cardiac Surgery With Cardiopulmonary Bypass : a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02866578
Acronym
PROVECS
Enrollment
494
Registered
2016-08-15
Start date
2016-09-23
Completion date
2018-05-07
Last updated
2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia

Brief summary

Cardiac surgery with cardiopulmonary bypass (CPB) frequently induces post-operative respiratory dysfunction. The post-operative pulmonary complications (PPCs) significantly increase the peri-operative morbidity and require invasive treatments during longer and more expensive ICU stays. A specific pathophysiology involving general anesthesia and CPB-related factors (inflammation, pulmonary ischemia) has been clearly demonstrated and pulmonary atelectasis seems to play a central role in the occurence of these PPCs. The open lung approach is a ventilation strategy that aims to open the lung and keep it open using different ventilatory settings. The efficacy of that strategy is not demonstrated in the global surgical population. However, its application in the perioperative care of cardiac surgery patients could be of great interest by counteracting the development of atelectasis. The purpose of this multicentre, double blinded, randomized controlled study is to evaluate the influence of a perioperative multimodal protective ventilation strategy based on the open lung approach on postoperative outcomes during the first 7 days following cardiac surgery. Participating centres will include 500 adult patients undergoing scheduled on-pump cardiac surgery. The open lung approach will combine recruitment maneuvers (RM), positive end expiratory pressure (PEEP) at 8 cmH2O from intubation to detubation and continuation of ultraprotective ventilation during CPB. It will be compared to a conventional approach without RM, with PEEP at 2 cmH2O and discontinuation of ventilation during CPB. The primary endpoint is any post-operative pulmonary complication. The secondary endpoints are any post-operative extra-pulmonary complications and the number of ICU-free days to day 7.

Interventions

PROCEDUREOpen lung protective ventilation strategy

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Cardiac surgery planned with CPB and sternotomy. * Age \> 18 years old.

Exclusion criteria

* Urgent surgery : cardiac transplantation, aortic dissection, active endocarditis. * Aortic arch surgery with circulatory arrest. * LVAD surgery. * Acute or chronic preoperative hypoxemia (PaO2 \< 65 mmHg in air). * Preoperative shock state requiring catecholamines. * LVEF \< 40%. * Pulmonary hypertension with systolic pulmonary artery pressure \> 50 mmHg. * Severe right ventricular dysfunction (TDI tricuspid annular systolic velocity \< 10 cm.s-1). * Chronic kidney disease (Glomerular filtration rate \< 30 mL/min). * Body Mass Index \> 35kg/m2. * Patient's refusal.

Design outcomes

Primary

MeasureTime frameDescription
Post-operative pulmonary complications defined as a composite endpointfirst 7 days post-operatively.Mild hypoxemia Moderate hypoxemia Severe hypoxemia Severe bronchospam Radiological atelectasis Respiratory acidosis Pneumonia Pleural effusion Acute Respiratory Distress Syndrome Need for reintubation Need for reintubation

Secondary

MeasureTime frameDescription
Postoperative extrapulmonary complicationFirst 7 days post operativelySystemic inflammatory response syndrome Sepsis Septic chock Mediastinitis Pericardial tamponade Surgical bleeding Acute kidney failure (KDIGO stage 2 or 3) Postoperative atrial fibrillation Cardiogenic chock Delirium
ICU free DaysFirst 7 days post operativelyDays alive and free from the need of intensive care

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026